Top Banner

of 17

2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

Apr 14, 2018

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    1/17

    PREVIOUS NEXT

    PREVIOUS NEXT

    Using Oracle's Empirica Topics to Document Your

    Signal Management Process

    July 26, 2013

    Rodney Lemery, MPH, PhD

    Vice President, Safety andPharmacovigilance

    BioPharm Systems, Inc.

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    2/17

    PREVIOUS NEXT

    Agenda

    Signal Management using Oracle Empirica

    Products Detection

    Use of e-Signal for data mining

    Prioritization

    Evaluation

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    3/17

    PREVIOUS NEXT

    Signal Management

    The process of identifying, prioritizing and evaluating

    determined signals in a data population

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    4/17

    PREVIOUS NEXT

    Current Regulatory EnvironmentAs of July 2, 2012, the EMA has required among other things All validation, prioritisation, assessment, timelines, decisions, actions, plans,

    reporting as well as all other key steps should be recorded and trackedsystematically. Tracking systems should be used for documentation and should

    also include signals, for which the validation process conducted was notsuggestive of a new potentially causal association, or a new aspect of a knownassociation. All records need to be archived (EMA, 2012).

    In June of 2002, the US Congress reauthorized (for a secondtime) the Prescription Drug User Fee Act (PDUFA III)

    Specifically, FDA issued three concept papers. Each paper focused onone aspect of risk management, includingo (1) conducting premarketing risk assessment

    o (2) developing and implementing risk minimization tools

    o (3) performing post marketing pharmacovigilance and pharmacoepidemiologicassessments. (FDA, 2005)

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    5/17

    PREVIOUS NEXT

    What the Industry Seeks

    A systematic approach to signalmanagement

    Ability to identify potential issues in clinical and post-marketing data

    Standard prioritization questions

    Standard evaluation methods to feed risk management

    Pre-defined workflow for these processes

    A system to collect and track thisapproach Standard system to document the identification,

    prioritization and evaluation of signals

    Capability to report this process for audit answeringand justification or risk methods (document duediligence)

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    6/17

    PREVIOUS NEXT

    Empirica Topics Workflow Example

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    7/17PREVIOUS NEXT

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    8/17PREVIOUS NEXT

    Actions can be created and assigned to other users in the company

    In this example, an action to review the case series is assigned

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    9/17PREVIOUS NEXT

    Signals prioritized as

    High or Medium are

    moved into the Signal

    Evaluation workflowstep for further

    investigation and

    signal workup

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    10/17PREVIOUS NEXT

    Additional

    external

    documentationcan also be

    attached to the

    topic to

    support the

    prioritization of

    the signal

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    11/17PREVIOUS NEXT

    Using e-Signal, we can drill

    down into the case series

    that makes up the signal of

    interest

    The case series can

    be attached to the

    topic of interest for

    historical

    identification

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    12/17PREVIOUS NEXT

    Additional

    external

    documentati

    on can alsobe attached

    to the topic

    to support

    the

    evaluationof the signal

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    13/17PREVIOUS NEXT

    Using the default abilities of e-Topics, we can run reports documenting

    our signal management process at the request of a regulatory

    authority or equivalent

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    14/17PREVIOUS NEXT

    Complete auditing of the topic case

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    15/17PREVIOUS NEXT

    Summary

    Using existing literature and Empirica Suite can be configured to

    provide a systematic method for signal management in a single

    solution that accomplishes the following:

    Ability to identify potential issues in clinical and post-marketingdata

    Standard prioritization questions

    Standard evaluation methods to feed risk management

    Pre-defined workflow for these processes

    Capability to report this process for audit answering and

    justification or risk methods (document due diligence)

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    16/17PREVIOUS NEXT

    References Bennett Levitan, B., Yee, C. L., Russo,L., Bayney, R., Thomas, A. P. and Klincewicz, S.

    L.. (2008). A Model for Decision Support in Signal Triage. Drug Safety. 31 (9), pp.727-735

    Council for International Organizations of Medical Sciences (CIOMS). (2010).

    Practical Aspects of Signal Detection in Pharmacovigilance. Report of CIOMSWorking Group VIII, Geneva .

    Heeley E, Waller P, and Moseley J. (2005). Testing and implementing signal impactanalysis in a regulatory setting: results of a pilot study. Drug Safety28 (10), pp.901-6

    Waller P, Heeley E, and Moseley J. (2005). Impact analysis of signals detectedfrom spontaneous adverse drug reaction reporting. Drug Safety28 (1), pp. 843-50

    Waller P, Lee E. (1999). Responding to drug safety issues. Pharmacoepidemiologyand Drug Safety8 (7), pp. 535-52

    Waller, P. (2010). An Introduction to Pharmacovigilance. Wiley-Blackwell. Oxford,UK

  • 7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process

    17/17PREVIOUS NEXT

    Questions & Answers

    2000 Alameda de las PulgasSuite 154

    San Mateo, CA 94403-1270

    www.biopharm.com

    Rodney L. Lemery MPH, PhDVice Pres. Safety and PV

    Tel (650) 292-5310

    Fax (650) 292-5301

    [email protected]

    http://www.biopharm.com/mailto:[email protected]:[email protected]://www.biopharm.com/